Antikor Business

Antikor has laboratory facilities at the Stevenage Bioscience Catalyst, just north of London. Here, a team of antibody engineers, synthetic chemists and bio-conjugation experts carry out the innovation needed to discover and develop FDC products. Scaled up R&D and pre-clinical testing is out-sourced. Antikor is currently carryng out R&D as follows:

• Developing Antikor's first product for gastric cancer
• Expanding the Company platform by developing its 'discovery engine' in order to generate a pipeline of FDCs towards any target, focussing on oncology.
• Strengthening the Company platform by examining the FDCs product characteristics such as toxicology and efficacy profile.
• Filing and prosecuting the core FDC patents in the major territories and addressing the various patent office actions
• Providing data for commercial partners in order to secure value-enhancing partnership or licensing deals

Antikor's current pipeline: